HHAT and benign prostatic hyperplasia: Although there is no prospective randomized study in the current literature, the data of existing case series (Table 1) and comparative studies (Table 2) suggest that RASP is a safe and efficacious procedure in the treatment of BPH patients with >80 gr of prostate size.